Skip to content

Prevention of Sacral Pressure Ulcers With Preventive Dressings

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01640418
Acronym
SACRESS
Enrollment
253
Registered
2012-07-13
Start date
2012-09-30
Completion date
2013-10-31
Last updated
2015-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Grade I to Grade IV Pressure Ulcers in Higher Risk Patients

Keywords

pressure ulcer, dressing, prevention, higher risk patients

Brief summary

In this study we would like to find a way to prevent sacral pressure ulcers in high-risk patients by the use of a Mepilex sacral dressing. The research question we would like to answer is the following: Is the Mepilex sacral dressing a cost-effective dressing for the prevention of grade I to grade IV pressure ulcers in the sacral region in higher-risk hospitalized patients?

Interventions

DEVICEMepilex® Border Sacrum dressings

Mepilex® Border Sacrum dressings

Sponsors

Maastricht University Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age: ≥18 years * Admission in one of the ten high-risk departments of the azM * Suspected hospital stay of 5 days or more after admission * Braden score 19 or less

Exclusion criteria

* Age: \<18 years * Pre-existing sacral pressure ulcer * Pre-existing trauma to the sacrum * Patient is unable to speak Dutch * Patients with an inability to give informed consent * Patients who are unable to give informed consent within 24h after admission * Patients who are unable to give informed consent before surgery

Design outcomes

Primary

MeasureTime frameDescription
To compare the number of patients who develop sacral pressure ulcers between the group with the Mepilex® Border Sacrum dressings (Group A) and the group without any sacral dressings (Group B).8 weekstill hospital release, max 8 weeks

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026